Extendicare Stock Return On Equity
| EXE Stock | CAD 10.33 0.03 0.29% |
Extendicare fundamentals help investors to digest information that contributes to Extendicare's financial success or failures. It also enables traders to predict the movement of Extendicare Stock. The fundamental analysis module provides a way to measure Extendicare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Extendicare stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 0.39 | 0.30 |
Extendicare | Return On Equity |
Extendicare Company Return On Equity Analysis
Extendicare's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Extendicare Return On Equity | 0.6 |
Most of Extendicare's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Extendicare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Extendicare Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Extendicare is extremely important. It helps to project a fair market value of Extendicare Stock properly, considering its historical fundamentals such as Return On Equity. Since Extendicare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Extendicare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Extendicare's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Extendicare Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Extendicare has a Return On Equity of 0.6. This is 102.5% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on equity for all Canada stocks is notably lower than that of the firm.
Extendicare Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Extendicare's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Extendicare could also be used in its relative valuation, which is a method of valuing Extendicare by comparing valuation metrics of similar companies.Extendicare is currently under evaluation in return on equity category among its peers.
Extendicare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Extendicare from analyzing Extendicare's financial statements. These drivers represent accounts that assess Extendicare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Extendicare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 752.4M | 596.3M | 656.9M | 583.9M | 610.2M | 861.8M | |
| Enterprise Value | 1.2B | 981.0M | 1.1B | 800.6M | 869.5M | 1.6B |
Extendicare Fundamentals
| Return On Equity | 0.6 | ||||
| Return On Asset | 0.0716 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 1.03 B | ||||
| Shares Outstanding | 83.47 M | ||||
| Shares Owned By Insiders | 13.92 % | ||||
| Shares Owned By Institutions | 19.14 % | ||||
| Number Of Shares Shorted | 848.63 K | ||||
| Price To Earning | 26.74 X | ||||
| Price To Book | 7.58 X | ||||
| Price To Sales | 0.62 X | ||||
| Revenue | 1.3 B | ||||
| Gross Profit | 108.53 M | ||||
| EBITDA | 98.61 M | ||||
| Net Income | 33.98 M | ||||
| Cash And Equivalents | 167.28 M | ||||
| Cash Per Share | 1.36 X | ||||
| Total Debt | 334.52 M | ||||
| Debt To Equity | 6.07 % | ||||
| Current Ratio | 1.04 X | ||||
| Book Value Per Share | 1.06 X | ||||
| Cash Flow From Operations | 23.28 M | ||||
| Short Ratio | 9.87 X | ||||
| Earnings Per Share | 0.73 X | ||||
| Target Price | 10.5 | ||||
| Beta | 1.28 | ||||
| Market Capitalization | 862.21 M | ||||
| Total Asset | 672.73 M | ||||
| Retained Earnings | (393.47 M) | ||||
| Working Capital | (39.25 M) | ||||
| Current Asset | 211.37 M | ||||
| Current Liabilities | 218.02 M | ||||
| Annual Yield | 0.05 % | ||||
| Five Year Return | 5.98 % | ||||
| Net Asset | 672.73 M |
About Extendicare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Extendicare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Extendicare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Extendicare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Extendicare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.Moving together with Extendicare Stock
Moving against Extendicare Stock
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.